Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease

BACKGROUND AND AIMS: Thrombocytopenia is a common complication in patients with chronic hepatitis C virus (HCV) that increases the risk of bleeding. We aimed to analyze the hematologic effects of the new direct-acting antiviral (DAA) therapy, particularly on the platelet count in chronic HCV-infecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Saif-Al-Islam, Mahmoud, Abdelaal, Usama M., Younis, Mustafa Adel, Alghany Algahlan, Hisham A., Khalaf, Safaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169259/
https://www.ncbi.nlm.nih.gov/pubmed/34122539
http://dx.doi.org/10.1155/2021/8811203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169259/
https://www.ncbi.nlm.nih.gov/pubmed/34122539
http://dx.doi.org/10.1155/2021/8811203

Ejemplares similares